1. Adverse reactions to health products reported in Canada in 2022

   News item 13 January 2024 Pages: 1 - 1

2. Coughing during or after use of Viatris inhaler

   News item 13 January 2024 Pages: 2 - 2

3. FDA warns against use of counterfeit Ozempic (semaglutide)

   News item 13 January 2024 Pages: 3 - 3

4. Promethazine hydrochloride injection labelling updates

   News item 13 January 2024 Pages: 4 - 4

5. Ustekinumab: lupus-related conditions and opportunistic infections

   News item 13 January 2024 Pages: 5 - 5

6. Venlafaxine: updated warning regarding risk of overdose

   News item 13 January 2024 Pages: 6 - 6

7. ConcePTION project improving data collection in pregnancy safety studies

   Clinical study 13 January 2024 Pages: 7 - 7

8. Diabetes increases risk of ADRs in elderly hospitalised patients

   Clinical study 13 January 2024 Pages: 8 - 8

9. Differences in rates of AESIs between COVID-19 vaccine types

   Clinical study 13 January 2024 Pages: 9 - 9

10. Paracetamol overdose-related intestinal injury

    Clinical study 13 January 2024 Pages: 10 - 10

11. Risk factors for haemorrhage in patients receiving cefazolin

    Clinical study 13 January 2024 Pages: 11 - 11

12. SRIs increase risk of antithrombotic-related haemorrhage

    Clinical study 13 January 2024 Pages: 12 - 12

13. Other adverse reaction research

    News item 13 January 2024 Pages: 13 - 13

14. Acenocoumarol

    Case report 13 January 2024 Pages: 14 - 14

15. Ad5-nCoV-Tianjin-CanSino-Biotechnology

    Case report 13 January 2024 Pages: 15 - 15

16. Adalimumab/sulfasalazine

    Case report 13 January 2024 Pages: 16 - 16

17. Amfetamine

    Case report 13 January 2024 Pages: 17 - 17

18. Amoxicillin/amoxicillin/clavulanic acid

    Case report 13 January 2024 Pages: 18 - 18

19. Amphotericin-B

    Case report 13 January 2024 Pages: 19 - 19

20. Amphotericin-B-liposomal

    Case report 13 January 2024 Pages: 20 - 20

21. Ampicillin

    Case report 13 January 2024 Pages: 21 - 21

22. Antineoplastics

    Case report 13 January 2024 Pages: 22 - 22

23. Antineoplastics

    Case report 13 January 2024 Pages: 23 - 23

24. Antineoplastics/Norepinephrine

    Case report 13 January 2024 Pages: 24 - 24

25. Antirheumatics/vedolizumab

    Case report 13 January 2024 Pages: 25 - 25

26. Apremilast/betamethasone/triamcinolone

    Case report 13 January 2024 Pages: 26 - 26

27. Aripiprazole

    Case report 13 January 2024 Pages: 27 - 27

28. Aripiprazole/Quetiapine

    Case report 13 January 2024 Pages: 28 - 28

29. AZD-1222

    Case report 13 January 2024 Pages: 29 - 29

30. Azithromycin/Methotrexate/Mercaptopurine

    Case report 13 January 2024 Pages: 30 - 30

31. Azosemide/pergolide

    Case report 13 January 2024 Pages: 31 - 31

32. Baricitinib/dexamethasone/remdesivir

    Case report 13 January 2024 Pages: 32 - 32

33. Batroxobin/Somatostatin

    Case report 13 January 2024 Pages: 33 - 33

34. Bevacizumab/carboplatin/paclitaxel

    Case report 13 January 2024 Pages: 34 - 34

35. Bilastine/Deflazacort/Paracetamol/codeine

    Case report 13 January 2024 Pages: 35 - 35

36. Buprenorphine/Fentanyl

    Case report 13 January 2024 Pages: 36 - 36

37. Buprenorphine/Fentanyl

    Case report 13 January 2024 Pages: 37 - 37

38. Buprenorphine/naloxone/fentanyl

    Case report 13 January 2024 Pages: 38 - 38

39. Caffeine/coffea

    Case report 13 January 2024 Pages: 39 - 39

40. Calcitriol/calcium/vitamin-D

    Case report 13 January 2024 Pages: 40 - 40

41. Camrelizumab

    Case report 13 January 2024 Pages: 41 - 41

42. Capecitabine

    Case report 13 January 2024 Pages: 42 - 42

43. Carboplatin/durvalumab/etoposide

    Case report 13 January 2024 Pages: 43 - 43

44. Carboplatin/olaparib/paclitaxel

    Case report 13 January 2024 Pages: 44 - 44

45. Carboplatin/osimertinib/pemetrexed

    Case report 13 January 2024 Pages: 45 - 45

46. Cefalexin

    Case report 13 January 2024 Pages: 46 - 46

47. Cefazolin

    Case report 13 January 2024 Pages: 47 - 47

48. Cefoperazone/sulbactam/etoposide/vancomycin

    Case report 13 January 2024 Pages: 48 - 48

49. Ceftriaxone

    Case report 13 January 2024 Pages: 49 - 49

50. Chlorhexidine

    Case report 13 January 2024 Pages: 50 - 50